Healthcare provider profile · identity verified

Kenneth M Ripp, M.D.

Family Practice · CLOQUET, MN · NPI 1245312537

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	791	173
Atorvastatin Calcium	Atorvastatin Calcium	645	145
Metoprolol Succinate	Metoprolol Succinate	409	102
Lisinopril	Lisinopril	342	83
Ramipril	Ramipril	314	75
Levothyroxine Sodium	Levothyroxine Sodium	264	50
Omeprazole	Omeprazole	255	62
Tamsulosin Hcl	Tamsulosin Hcl	248	63
Metformin Hcl	Metformin Hcl	230	53
Sertraline Hcl	Sertraline Hcl	210	39
Furosemide	Furosemide	203	31
Losartan Potassium	Losartan Potassium	199	50
Chlorthalidone	Chlorthalidone	188	52
Allopurinol	Allopurinol	171	46
Rosuvastatin Calcium	Rosuvastatin Calcium	158	41
Simvastatin	Simvastatin	156	38
Hydrochlorothiazide	Hydrochlorothiazide	151	44
Spironolactone	Spironolactone	151	33
Gabapentin	Gabapentin	146	36
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	134	48
Warfarin Sodium	Warfarin Sodium	106	25
Citalopram Hbr	Citalopram Hydrobromide	94	24
Eliquis	Apixaban	91	16
Mirtazapine	Mirtazapine	91	12
Carvedilol	Carvedilol	88	21
Jardiance	Empagliflozin	85	14
Donepezil Hcl	Donepezil Hcl	84	suppressed
Xarelto	Rivaroxaban	82	20
Jantoven	Warfarin Sodium	81	suppressed
Duloxetine Hcl	Duloxetine Hcl	80	13
Pantoprazole Sodium	Pantoprazole Sodium	79	21
Albuterol Sulfate Hfa	Albuterol Sulfate	77	30
Potassium Chloride	Potassium Chloride	75	19
Clopidogrel	Clopidogrel Bisulfate	73	16
Irbesartan	Irbesartan	71	14
Lorazepam	Lorazepam	68	14
Metoprolol Tartrate	Metoprolol Tartrate	64	21
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	62	17
Ozempic	Semaglutide	60	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	59	14
Famotidine	Famotidine	59	12
Clonazepam	Clonazepam	55	11
Trazodone Hcl	Trazodone Hcl	55	16
Valsartan	Valsartan	54	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	53	suppressed
Glimepiride	Glimepiride	52	15
Zolpidem Tartrate	Zolpidem Tartrate	52	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	51	suppressed
Prednisone	Prednisone	51	20
Alendronate Sodium	Alendronate Sodium	50	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	50	14
Carbidopa-Levodopa	Carbidopa/Levodopa	48	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	47	30
Pregabalin	Pregabalin	46	suppressed
Atenolol	Atenolol	44	suppressed
Finasteride	Finasteride	44	suppressed
Ventolin Hfa	Albuterol Sulfate	44	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	43	suppressed
Metformin Hcl Er	Metformin Hcl	41	suppressed
Paroxetine Hcl	Paroxetine Hcl	40	suppressed
Pravastatin Sodium	Pravastatin Sodium	39	suppressed
Ropinirole Hcl	Ropinirole Hcl	38	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	34	suppressed
Nitroglycerin	Nitroglycerin	34	16
Alprazolam	Alprazolam	32	suppressed
Tramadol Hcl	Tramadol Hcl	32	suppressed
Torsemide	Torsemide	30	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	30	suppressed
Nystatin	Nystatin	29	suppressed
Diazepam	Diazepam	28	suppressed
Bupropion Hcl Sr	Bupropion Hcl	27	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	27	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	25	suppressed
Montelukast Sodium	Montelukast Sodium	24	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	24	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	24	19
Bupropion Xl	Bupropion Hcl	23	suppressed
Adderall Xr	Dextroamphetamine/Amphetamine	22	suppressed
Midodrine Hcl	Midodrine Hcl	22	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	22	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	21	14
Hysingla Er	Hydrocodone Bitartrate	21	suppressed
Levetiracetam	Levetiracetam	21	suppressed
Loperamide	Loperamide Hcl	21	suppressed
Methocarbamol	Methocarbamol	20	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	20	suppressed
Clonidine Hcl	Clonidine Hcl	19	suppressed
Gemfibrozil	Gemfibrozil	19	suppressed
Oxycodone Hcl	Oxycodone Hcl	19	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	18	suppressed
Unifine Pentips	Pen Needle, Diabetic	18	suppressed
Celecoxib	Celecoxib	17	suppressed
Fluticasone Propionate	Fluticasone Propionate	17	suppressed
Klor-Con M20	Potassium Chloride	17	suppressed
Meclizine Hcl	Meclizine Hcl	17	suppressed
Terazosin Hcl	Terazosin Hcl	17	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	16	16
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	16	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	15	suppressed
Buspirone Hcl	Buspirone Hcl	15	suppressed
Cephalexin	Cephalexin	15	13
Spiriva Respimat	Tiotropium Bromide	15	suppressed
Amoxicillin	Amoxicillin	14	11
Incruse Ellipta	Umeclidinium Bromide	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Victoza 3-Pak	Liraglutide	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Glipizide Er	Glipizide	13	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Olanzapine	Olanzapine	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Breyna	Budesonide/Formoterol Fumarate	12	suppressed
Cholestyramine	Cholestyramine (With Sugar)	12	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	12	suppressed
Prenatal Vitamin Plus Low Iron	Pnv,calcium 72/Iron/Folic Acid	12	suppressed
Primidone	Primidone	12	suppressed
Tresiba Flextouch U-100	Insulin Degludec	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Novolog Flexpen	Insulin Aspart	11	suppressed
Tizanidine Hcl	Tizanidine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error